Lifastuzumab vedotin, CAS [[1401812-88-1]]

Produktübersicht

• Artikelname: Lifastuzumab vedotin, CAS [[1401812-88-1]]
• Artikelnummer: TGM-T9901A-025
• Hersteller Artikelnummer: T9901A-025
• Alternativnummer: TGM-T9901A-025-1MG,TGM-T9901A-025-5MG,TGM-T9901A-025-10MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: DNIB0600A

Produktbeschreibung

Lifastuzumab vedotin (DNIB0600A), an antibody-drug conjugate (ADC), consists of a humanized IgG1 monoclonal antibody targeting NaPi2b (MNIB2126A) linked to the potent antimitotic agent monomethyl auristatin E (MMAE), which disrupts cell division by inhibiting tubulin polymerization. This compound shows promise for research in non-small cell lung cancer (NSCLC) and platinum-resistant ovarian cancer (PROC) [1].

Produkteigenschaften

• CAS Nummer: [1401812-88-1]
• Target-Kategorie: Antibody-Drug Conjugates (ADCs)|||Others